Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Keith C Bible"'
Autor:
Sara Bedrose, Kevin Charles Miller, Lina Altameemi, Mohamed S Ali, Sameh Nassar, Naveen Garg, Marilyne Daher, Keith D Eaton, Jeffrey Thomas Yorio, Davey B Daniel, Keith C Bible, Ashish V Chintakuntlawar, Mouhammed Amir Habra
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Externí odkaz:
https://doaj.org/article/7f38fd3eb9c14fb2abdc99286e69b0ad
Autor:
Sara Bedrose, Kevin Charles Miller, Lina Altameemi, Mohamed S Ali, Sameh Nassar, Naveen Garg, Marilyne Daher, Keith D Eaton, Jeffrey Thomas Yorio, Davey B Daniel, Keith C Bible, Ashish V Chintakuntlawar, Mouhammed Amir Habra
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Personalized cell therapy targeting tumor antigens with expanded tumor-infiltrating lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s. However, MM was first-in line to benefit from the wave of checkpoint inhibitors
Externí odkaz:
https://doaj.org/article/0283487c583b4f2dad1a44097f01e3a7
Autor:
Sara Bedrose, Kevin Charles Miller, Lina Altameemi, Mohamed S Ali, Sameh Nassar, Naveen Garg, Marilyne Daher, Keith D Eaton, Jeffrey Thomas Yorio, Davey B Daniel, Keith C Bible, Ashish V Chintakuntlawar, Mouhammed Amir Habra
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background There is no effective systemic therapy for metastatic adrenal cortical carcinoma (ACC) after failure of platinum-based chemotherapy. The efficacies of single-agent oral multikinase inhibitors (MKIs) or salvage immune checkpoint inhibitors
Externí odkaz:
https://doaj.org/article/4a195cbe866047b8a6068d0918bac22f
Autor:
Mitesh J Borad, Mia D Champion, Jan B Egan, Winnie S Liang, Rafael Fonseca, Alan H Bryce, Ann E McCullough, Michael T Barrett, Katherine Hunt, Maitray D Patel, Scott W Young, Joseph M Collins, Alvin C Silva, Rachel M Condjella, Matthew Block, Robert R McWilliams, Konstantinos N Lazaridis, Eric W Klee, Keith C Bible, Pamela Harris, Gavin R Oliver, Jaysheel D Bhavsar, Asha A Nair, Sumit Middha, Yan Asmann, Jean-Pierre Kocher, Kimberly Schahl, Benjamin R Kipp, Emily G Barr Fritcher, Angela Baker, Jessica Aldrich, Ahmet Kurdoglu, Tyler Izatt, Alexis Christoforides, Irene Cherni, Sara Nasser, Rebecca Reiman, Lori Phillips, Jackie McDonald, Jonathan Adkins, Stephen D Mastrian, Pamela Placek, Aprill T Watanabe, Janine Lobello, Haiyong Han, Daniel Von Hoff, David W Craig, A Keith Stewart, John D Carpten
Publikováno v:
PLoS Genetics, Vol 10, Iss 2, p e1004135 (2014)
Advanced cholangiocarcinoma continues to harbor a difficult prognosis and therapeutic options have been limited. During the course of a clinical trial of whole genomic sequencing seeking druggable targets, we examined six patients with advanced chola
Externí odkaz:
https://doaj.org/article/72d9a122f58441d9a86d9254c686cd3b
Autor:
Eric J Sherman, Jonathan Harris, Keith C Bible, Ping Xia, Ronald A Ghossein, Christine H Chung, Nadeem Riaz, G Brandon Gunn, Robert L Foote, Sue S Yom, Stuart J Wong, Shlomo A Koyfman, Michael F Dzeda, David A Clump, Saad A Khan, Manisha H Shah, Kevin Redmond, Pedro A Torres-Saavedra, Quynh-Thu Le, Nancy Y Lee
Publikováno v:
The Lancet Oncology. 24:175-186
Autor:
Keith C. Bible, Irene Brana, Mollie Leoni, Stephan Hackenberg, Jessica Bauman, Pol Specenier, Jérôme Fayette, Catherine Rose Scholz, Binaifer Balsara, Maria Jose Flor, Bridget Martell, Alan L. Ho, Robert I. Haddad, Valentina Boni, Caroline Even, Sjoukje F. Oosting, Sung-Bae Kim, Kevin J. Harrington, Nabil F. Saba, Francis P. Worden, Antonio Gualberto, Lisa Licitra, Ioanna Nixon, Deborah J. Wong, Myung-Ju Ahn
Publikováno v:
Journal of clinical oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(17):JCO2002903, 1856-1864. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(17):JCO2002903, 1856-1864. AMER SOC CLINICAL ONCOLOGY
PURPOSEMutations in the HRAS (m HRAS) proto-oncogene occur in 4%-8% of patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Tipifarnib is a farnesyltransferase inhibitor that disrupts HRAS function. We evalua
Autor:
Electron Kebebew, James Brierley, Carol K. Wong-Clark, Thomas J. Giordano, Gregory W. Randolph, Anna M. Sawka, Maria E. Cabanillas, M. Sara Rosenthal, Keith C. Bible, Robert L. Foote, Thomas J. Clark, Ashok R. Shaha, Yuri E. Nikiforov, Manisha H. Shah, Kate Newbold, Juan P. Brito, Jan L. Kasperbauer, Robert C. Smallridge, Antonio Di Cristofano
Publikováno v:
Thyroid
Background: Anaplastic thyroid cancer (ATC) is a rare but highly lethal form of thyroid cancer. Since the guidelines for the management of ATC by the American Thyroid Association were first published in 2012, significant clinical and scientific advan
Autor:
David C. Shonka, Alan Ho, Ashish V. Chintakuntlawar, Jessica L. Geiger, Jong C. Park, Nagashree Seetharamu, Sina Jasim, Amr H. Abdelhamid Ahmed, Keith C. Bible, Marcia S. Brose, Maria E. Cabanillas, Kirsten Dabekaussen, Louise Davies, Dora Dias‐Santagata, James A. Fagin, William C. Faquin, Ronald A. Ghossein, Raj K. Gopal, Akira Miyauchi, Yuri E. Nikiforov, Matthew D. Ringel, Bruce Robinson, Mabel M. Ryder, Eric J. Sherman, Peter M. Sadow, Jennifer J. Shin, Brendan C. Stack, R. Michael Tuttle, Lori J. Wirth, Mark E. Zafereo, Gregory W. Randolph
Publikováno v:
Head Neck
BACKGROUND: The development of systemic treatment options leveraging the molecular landscape of advanced thyroid cancer is a burgeoning field. This is a multidisciplinary evidence-based statement on the definition of advanced thyroid cancer and its t
Autor:
Crystal Hilger, Sina Jasim, Michael E. Menefee, Nicole M. Iñiguez-Ariza, Mabel Ryder, Robert C. Smallridge, Keith C. Bible, Nina J. Karlin, Ashish V. Chintakuntlawar, Constanza Alcaino, John C. Morris
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 105:e2346-e2357
Context Clinical applications of genomic assessment of thyroid cancers are rapidly evolving. Objectives, Design, and Setting We studied tumor samples from patients with imminently threatening and rare thyroid cancers to identify genomic alterations t
Autor:
Lauren Hassan Nelson, Harry Fuentes-Bayne, Jun Yin, Erik Asmus, Mabel Ryder, John C Morris, Crystal R Hilger, Keith C Bible, Ashish V Chintakuntlawar, Sarika N Rao
Publikováno v:
Journal of the Endocrine Society. 6(5)
Context Metastatic pheochromocytomas and paragangliomas (mPPGL) are rare vascular neuroendocrine tumors that highly express vascular growth factors. Systemic treatment options in cases of unresectable multisite disease are limited. Multikinase inhibi